Key result
A locally derived point-of-care NT pro-BNP cut-off of 171 pg/mL demonstrated better diagnostic accuracy for CHF (sensitivity 88.1%, specificity 93.3%) than the manufacturer's 125 pg/mL cut-off.
Why the study?
Does a locally derived NT-proBNP cut-off value improve diagnostic accuracy for CHF compared to the manufacturer's recommended value in a Nigerian population?
Case-Control (n=72)
Does a locally derived NT-proBNP cut-off value improve diagnostic accuracy for CHF compared to the manufacturer's recommended value in a Nigerian population?
A locally derived point-of-care NT-proBNP cut-off value of 171 pg/mL demonstrated better diagnostic performance for CHF in a Nigerian population than the manufacturer's recommended 125 pg/mL.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
A 2010 study conducted a case-control in Congestive Heart Failure (n=72). Point-of-care NT pro-BNP cut-off of 171 pg/mL vs. Manufacturer's cut-off of 125 pg/mL was evaluated on Sensitivity for diagnosing CHF. A locally derived point-of-care NT pro-BNP cut-off of 171 pg/mL demonstrated better diagnostic accuracy for CHF (sensitivity 88.1%, specificity 93.3%) than the manufacturer's 125 pg/mL cut-off.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: